Biomedical Engineering Reference
In-Depth Information
105. D.B. Chen, T.Z. Yang, W.L. Lu, and Q. Zhang,
In vitro
and
in vivo
study of two types of long-circulating
solid lipid nanoparticles containing paclitaxel,
Chemical and Parmaceutical Bulletin
49 (2001)
1444-1447.
106. Y.W. Cho, S.A. Park, T.H. Han, D.H. Son, J.S. Park, S.J. Oh, D.H. Moon, K. Cho, C. Ahn, Y. Byun, I. Kim,
I.C. Kwon, and S.Y. Kim,
In vivo
tumor targeting and radionuclide imaging with self-assembled nanopar-
ticles: Mechanisms, key factors, and their implications,
Biomaterials
28 (2007) 1236-1247.
107. T. Okuda, S. Kawakami, N. Akimoto, T. Niidome, F. Yamashita, and M. Hashida, PEGylated lysine
dendrimers for tumor-selective targeting after intravenous injection in tumor-bearing mice,
Journal of
Controlled Release
116 (2006) 330-336.
108. S.Q. Liu, N. Wiradharma, S.J. Gao, Y.W. Tong, and Y.Y. Yang, Bio-functional micelles self-assembled
form a folate-conjugated block copolymer for targeted intracellular delivery of anticancer drugs,
Biomaterials
28 (2007) 1423-1433.
109. S. Dagar, A. Krishnadas, I. Rubinstein, M.J. Blend, and H. Onyuksel, VIP grafted sterically stabilized
liposomes for targeted imaging of breast cancer:
In vivo
studies,
Journal of Controlled Release
91
(2003) 123-133.
110. S. Hosokawa, T. Tagawa, H. Niki, Y. Hirakawa, K. Nohga, and K. Nagaike, Effi cacy of immunolipo-
somes on cancer models in a cell-surface-antigen-density-dependent manner,
British Journal of Cancer
89 (2003) 1545-1551.
111. P. Sapra and T.M. Allen, Ligand-targeted liposomal anticancer drugs,
Progress in Lipid Research
42
(2003) 439- 462.
